George G Schweitzer1, Gregory D Cartee. 1. Muscle Biology Laboratory, School of Kinesiology, Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract
UNLABELLED: A single exercise bout stimulates skeletal muscle glucose transport (GT) in the absence or presence of insulin. It has been suggested that the kallikrein-kinin system may contribute to exercise effects on both insulin-independent and insulin-dependent GT. Plasma kininogen, a key kallikrein-kinin system component, is a protein substrate for the enzyme kallikrein and the source of the peptide bradykinin. PURPOSE: This study aimed to determine whether the postexercise (PEX) increase in insulin-dependent or insulin-independent GT is reduced in rats deficient in plasma kininogen versus normal rats. METHODS: Male Brown Norway (BN) and Brown Norway Katholiek (BNK; plasma kininogen-deficient) rats were studied. BN and BNK rats were assigned to exercise (4×30-min swim) or sedentary (SED) groups. Rats were anesthetized immediately (0hPEX) or 3 h (3hPEX) after exercise. For 0hPEX and 0hSED rats, one epitrochlearis muscle per rat was used for AMPK phosphorylation and muscle glycogen analyses. The contralateral muscle was incubated with [H]-3-O-methylglucose (3-MG) for GT assay. For 3hPEX and 3hSED rats, one muscle from each rat was incubated without insulin, and the contralateral muscle was incubated with 60 μU·mL insulin, and both muscles were incubated with 3-MG for GT measurement. RESULTS: For 0hPEX versus 0hSED, both BN and BNK rats had greater insulin-independent GT and AMPK phosphorylation with reduced glycogen after exercise. No genotype effects were found 0hPEX. There was a significant main effect of exercise (3hPEX>3hSED) and no interaction between exercise and genotype for basal or insulin-stimulated GT. CONCLUSIONS: Plasma kininogen deficiency did not alter insulin-independent GT, AMPK phosphorylation, or glycogen depletion 0hPEX or insulin-dependent GT 3hPEX, suggesting that normal plasma kininogen is not essential for these important exercise effects.
UNLABELLED: A single exercise bout stimulates skeletal muscle glucose transport (GT) in the absence or presence of insulin. It has been suggested that the kallikrein-kinin system may contribute to exercise effects on both insulin-independent and insulin-dependent GT. Plasma kininogen, a key kallikrein-kinin system component, is a protein substrate for the enzyme kallikrein and the source of the peptide bradykinin. PURPOSE: This study aimed to determine whether the postexercise (PEX) increase in insulin-dependent or insulin-independent GT is reduced in rats deficient in plasma kininogen versus normal rats. METHODS: Male Brown Norway (BN) and Brown Norway Katholiek (BNK; plasma kininogen-deficient) rats were studied. BN and BNK rats were assigned to exercise (4×30-min swim) or sedentary (SED) groups. Rats were anesthetized immediately (0hPEX) or 3 h (3hPEX) after exercise. For 0hPEX and 0hSED rats, one epitrochlearis muscle per rat was used for AMPK phosphorylation and muscle glycogen analyses. The contralateral muscle was incubated with [H]-3-O-methylglucose (3-MG) for GT assay. For 3hPEX and 3hSED rats, one muscle from each rat was incubated without insulin, and the contralateral muscle was incubated with 60 μU·mL insulin, and both muscles were incubated with 3-MG for GT measurement. RESULTS: For 0hPEX versus 0hSED, both BN and BNK rats had greater insulin-independent GT and AMPK phosphorylation with reduced glycogen after exercise. No genotype effects were found 0hPEX. There was a significant main effect of exercise (3hPEX>3hSED) and no interaction between exercise and genotype for basal or insulin-stimulated GT. CONCLUSIONS: Plasma kininogen deficiency did not alter insulin-independent GT, AMPK phosphorylation, or glycogen depletion 0hPEX or insulin-dependent GT 3hPEX, suggesting that normal plasma kininogen is not essential for these important exercise effects.
Authors: Katsuhiko Funai; George G Schweitzer; Carlos M Castorena; Makoto Kanzaki; Gregory D Cartee Journal: Am J Physiol Endocrinol Metab Date: 2010-02-23 Impact factor: 4.310
Authors: Nour-Eddine Rhaleb; Xiao-Ping Yang; Masahiko Nanba; Edward G. Shesely; Oscar A. Carretero Journal: Hypertension Date: 2001-01 Impact factor: 10.190
Authors: T Taguchi; H Kishikawa; H Motoshima; K Sakai; T Nishiyama; K Yoshizato; A Shirakami; T Toyonaga; T Shirontani; E Araki; M Shichiri Journal: Metabolism Date: 2000-07 Impact factor: 8.694
Authors: M Majima; O Yoshida; H Mihara; T Muto; S Mizogami; Y Kuribayashi; M Katori; S Oh-ishi Journal: Hypertension Date: 1993-11 Impact factor: 10.190
Authors: O Kohlman; F de A Neves; M Ginoza; A Tavares; M L Cezaretti; M T Zanella; A B Ribeiro; I Gavras; H Gavras Journal: Hypertension Date: 1995-05 Impact factor: 10.190
Authors: Haiyan Wang; Edward B Arias; Kentaro Oki; Mark W Pataky; Jalal A Almallouhi; Gregory D Cartee Journal: Am J Physiol Endocrinol Metab Date: 2019-03-05 Impact factor: 4.310
Authors: Haiyan Wang; Edward B Arias; Mark W Pataky; Laurie J Goodyear; Gregory D Cartee Journal: Am J Physiol Endocrinol Metab Date: 2018-08-21 Impact factor: 4.310
Authors: R Y Asano; R A V Browne; M M Sales; G Arsa; J F V N Moraes; H J Coelho-Júnior; M R Moraes; I Oliveira-Silva; S E Atlas; J E Lewis; H G Simões Journal: Braz J Med Biol Res Date: 2017-09-12 Impact factor: 2.590